Tfg Asset Management Gp LTD Tarsus Pharmaceuticals, Inc. Transaction History
Tfg Asset Management Gp LTD
- $346 Million
- Q1 2025
A detailed history of Tfg Asset Management Gp LTD transactions in Tarsus Pharmaceuticals, Inc. stock. As of the latest transaction made, Tfg Asset Management Gp LTD holds 178,470 shares of TARS stock, worth $8.04 Million. This represents 2.65% of its overall portfolio holdings.
Number of Shares
178,470
Previous 200,000
10.76%
Holding current value
$8.04 Million
Previous $11.1 Million
17.21%
% of portfolio
2.65%
Previous 3.62%
Shares
8 transactions
Others Institutions Holding TARS
# of Institutions
201Shares Held
44.5MCall Options Held
19.9KPut Options Held
7.6K-
Rtw Investments, LP New York, NY3.32MShares$149 Million2.79% of portfolio
-
Black Rock Inc. New York, NY3.27MShares$147 Million0.0% of portfolio
-
Paradigm Biocapital Advisors LP New York, NY2.61MShares$118 Million6.87% of portfolio
-
Jennison Associates LLC2.49MShares$112 Million0.09% of portfolio
-
Tang Capital Management LLC San Diego, CA2.45MShares$111 Million8.19% of portfolio
About Tarsus Pharmaceuticals, Inc.
- Ticker TARS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 26,658,500
- Market Cap $1.2B
- Description
- Tarsus Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of novel therapeutic candidates for ophthalmic conditions. Its lead product candidate is TP-03, a novel therapeutic that is in Phase III for the treatment of blepharitis caused by the infestation of Demodex mites, as well as...